REDWOOD CITY, Calif., June 12, 2023 Adverum Biotechnologies, Inc. , a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases,. | June 12, 2023
BML Capital Management LLC bought a new stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 7,067,179 shares of the biotechnology company’s stock, valued at approximately $4,095,000. Adverum Biotechnologies comprises about 3.9% of […]
REDWOOD CITY, Calif., June 02, 2023 Adverum Biotechnologies, Inc. , a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular. | June 2, 2023
Adverum Biotechnologies Announces New Executive Leadership Roles streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Adverum Biotechnologies (ADVM) Announces New Executive Leadership Roles streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.